Virtus NFJ International Value Inst holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
- NAV / 1-Day Return 27.79 / +0.83 %
- Total Assets 83.1M
-
Adj. Expense Ratio
0.950%
- Expense Ratio 1.060%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1M
- Status Open
- TTM Yield 5.08%
- Turnover 56%
USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 12:07 AM GMT+0
Morningstar’s Analysis ANJIX
Will ANJIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the ANJIX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of ANJIX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 39.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Taiwan Semiconductor Manufacturing Co Ltd | 6.84 | 6M | Technology |
Alibaba Group Holding Ltd Ordinary Shares | 4.58 | 4M | Consumer Cyclical |
Alphabet Inc Class A | 4.41 | 4M | Communication Services |
ASML Holding NV | 4.05 | 3M | Technology |
Us Dollar | 4.05 | 3M | Cash and Equivalents |
Standard Chartered PLC | 3.97 | 3M | Financial Services |
Cathay General Bancorp | 3.78 | 3M | Financial Services |
JD.com Inc Ordinary Shares - Class A | 3.50 | 3M | Consumer Cyclical |
Astellas Pharma Inc | 3.45 | 3M | Healthcare |
Tencent Holdings Ltd | 2.72 | 2M | Communication Services |
United States